Sign in

CIK 0000899460

  • Large accelerated filer

MANNKIND CORP

Sign in to watch
Ticker
MNKD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133607736
Phone
+1 818-661-5000
Business address
1 CASPER STREET, DANBURY, CT, 06810
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award Chief People & Workpl Officer acquired 147,717 shares (grant or award)
  7. 4 Grant or award Chief Technology Officer acquired 147,895 shares (grant or award)
  8. 4 Grant or award EVP Genl Counsel & Secretary acquired 148,412 shares (grant or award)
  9. 4 Grant or award Chief Financial Officer acquired 148,074 shares (grant or award)
  10. 4 Grant or award Chief Executive Officer acquired 416,092 shares (grant or award)
  11. 4 Grant or award Chief Commercial Officer acquired 144,000 shares (grant or award)
  12. 4 Open-market buy Chief Executive Officer bought 3,000 shares at $3.38 ($10,140)
  13. 4 Open-market buy Chief Financial Officer bought 1,557 shares at $1.33 ($2,071)
  14. 4 Open-market buy Chief People & Workpl Officer bought 5,000 shares at $1.33 ($6,650)
  15. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $1.33 ($6,650)
  16. 4 Shares withheld for taxes Chief People & Workpl Officer gave up 1,729 shares (to pay taxes)
  17. 4/A Open-market buy Chief Commercial Officer bought 34,602 shares at $2.89 ($100,000)
  18. 4 Open-market buy Chief Commercial Officer bought 34,602 shares at $2.89 ($100,000)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 14 of 50 · 999 filings